The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
helio genomics partners with halub medical to launch liver cancer test in middle east
Helio Genomics has partnered with Halub Medical Co. to commercialize HelioLiver Dx, a blood test for early liver cancer detection, in Saudi Arabia and the GCC, expected to launch in Q1 2025. The test, which shows superior sensitivity compared to ultrasound, aims to enhance liver cancer screening and is projected to generate over $10 million in revenue within its first year.